overweight
-
Professor Liping Zhao: Dysbiosis of the core microbiota is the root cause of human obesity！
The video is available for watching, too. Please visit DrugTimes. Many thanks!~
-
【Product for Licensing】siRNA Therapeutics Targeting INHBE and another target
If you are interested in this asset or need more information, please contact DrugTimes BD Team at BD@drugtimes.cn or visit our website at https://www.drugtimes.cn
-
Try again! Pfizer ‘revives’ its oral GLP-1RA
DrugTimes will present more reports. Please stay tuned
-
What is the Current Landscape of Obesity Drug Development in China?
These presentations indicate that the era of domestically developed GLP-1 drugs for weight loss in China is on the horizon, with significant implications for the future of obesity treatment
-
【Urgent】MNC, China big pharma, US biotech are looking for ActRIIA and ActRIIB Inhibitors for obesity and other indications
If your company is interested in this opportunity, please contact us as soon as possible!
